Correlation Between Sana Biotechnology and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Sana Biotechnology and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Vertex Pharmaceuticals.
Diversification Opportunities for Sana Biotechnology and Vertex Pharmaceuticals
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Sana and Vertex is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sana Biotechnology and Vertex Pharmaceuticals
Given the investment horizon of 90 days Sana Biotechnology is expected to under-perform the Vertex Pharmaceuticals. In addition to that, Sana Biotechnology is 2.33 times more volatile than Vertex Pharmaceuticals. It trades about -0.35 of its total potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about -0.11 per unit of volatility. If you would invest 47,637 in Vertex Pharmaceuticals on August 27, 2024 and sell it today you would lose (2,540) from holding Vertex Pharmaceuticals or give up 5.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sana Biotechnology vs. Vertex Pharmaceuticals
Performance |
| Timeline |
| Sana Biotechnology |
| Vertex Pharmaceuticals |
Sana Biotechnology and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sana Biotechnology and Vertex Pharmaceuticals
The main advantage of trading using opposite Sana Biotechnology and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |